Observational Study on the Impact of Herpes Zoster Vaccine on the Incidence of Herpes Zoster and Survival in Lung Cancer Patients

ConditionLung Cancer

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorThe First Affiliated Hospital of Guangzhou Medical University

About this trial

To evaluate the impact of herpes zoster vaccine on the incidence of herpes zoster and survival in lung cancer patients, and to explore its preventive effect and safety.

Eligibility criteria

Qualifiers

1.Male or female patients >=18 years of age; 2.Histological diagnosis of NSCLC, including both non-small cell lung cancer and small cell lung cancer, regardless of whether they are in the early, locally advanced stage or advanced stage, and regardless of whether they have received surgery, radiotherapy, chemotherapy or other treatments; 3. Never received herpes zoster vaccine

Disqualifiers

Patients having other factors that preventing researchers from enrollment them.

Trial design

Treatments tested in this trial

herpes zoster vaccine

Treatment groups

500 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

The First Affiliated Hospital of Guangzhou Medical University

Lead sponsor

Source ClinicalTrials.gov